COMPANY PROFILE · /cradle-bio
C
Cradle Bio
Protein engineering AI company using generative models to design improved biologics. Enables rapid design of proteins for therapeutics, diagnostics, and industrial biotech applications without extensive manual iteration.
Fresh · 9d ago
Latest valuation
estimated $500M
Annual Recurring Revenue
—
Headcount
80+
Funding total
$115M+
OVERVIEW
Raised $73M Series B in November 2024. Partners with Novo Nordisk, Johnson & Johnson, Grifols, Twist Biosciences. Focus on therapeutics, diagnostics, food, chemicals.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.